Alongside Statoil Technology Invest in the round are venture capital firms Investinor and ProVenture Management.
Month: October 2012
Amgen forms Atara
Venture capital firm Kleiner Perkins Caufield & Byers (KPCB) is providing the initial financing and management for Atara, while Amgen will have an equity stake.
Pfizer fizzes with Mirna
Alongside Pfizer Ventures in the C round were venture capital firms Sofinnova Ventures, which led the round, New Enterprise Associates (NEA), and Correlation Ventures and Osage University Partners, which backs university start-ups.
Qype gains Yelp’s good review
Yelp, a New York-listed website to review shops and restaurants, has acquired Qype, a Germany-based peer backed by mobile phone operator Vodafone’s corporate venturing unit. Yelp is paying $50m, made up of €18.6m ($24m) in cash and 970,000 class A shares of its stock. Alongside Vodafone Ventures among Qype’s investors are venture capital firms Advent… Continue reading Qype gains Yelp’s good review
Rogers meets Comcast at Tely Labs
Tely Labs, a US-based provider of a video phone system for consumers, has added Rogers Venture Partners, the corporate venturing unit of the eponymous Canada-based communications and media company, to its series A round consortium. Last month, Tely Labs disclosed in a regulatory filing it had raised $13m of a planned $15m round and this… Continue reading Rogers meets Comcast at Tely Labs
Radius Health sets flotation terms
Radius Health, a US-based developer of drug therapies for osteoporosis and women’s health, plans to sell 6.5 million shares at between $8.50 and $10.50 each in its Nasdaq stock exchange flotation. Investment banks UBS and Leerink Swann are co-lead underwriters of Radius’ initial public offering (IPO) that will give the company a $283m market capitalisation… Continue reading Radius Health sets flotation terms
DeNa and Sega sell Pokelabo
DeNA and Sega, two Japan-based online games developers, have sold Pokelabo from their corporate venturing portfolios to trade buyer Gree for $175m. In 2010, DeNA’s Incubate Fund and venture capital firm DCM invested a combined $11m (reportedly split $4.5m and $6.5m respectively) in Pokelabo. Last year, games maker Sega invested an undisclosed amount in Pokelabo… Continue reading DeNa and Sega sell Pokelabo
Qualcomm monitors Panoramic’s success
Panoramic Power, an Israel-based energy monitoring company, has raised $4.5m for its series B round from multiple corporations. Venture capital firms Israel Cleantech Ventures and Greylock Partners co-led Panoramic’s round, with participation from Clal Energy, Israel Electric Company (Karat Program), chip company Qualcomm’s Ventures unit and Alexander Schneider. Panromic, which had previously won Qualcomm’s Qprize… Continue reading Qualcomm monitors Panoramic’s success
NTT Docomo calls up Japan fund
The launch of the Y10bn ($125m) Docomo Innovation Fund and Docomo Innovation Village incubation programme is expected by March 31.
Amex swipes with Izettle
US-based credit card company American Express (Amex) has joined peer MasterCard as an investor in Izettle, a Sweden-based mobile payment system (whose staff are pictured). Amex provided an undisclosed amount to join Izettle’s series B round that initially closed last year at €25m ($32m). Alongside the two card companies in the B round are local… Continue reading Amex swipes with Izettle
HeartLab pumps up with Mutual Capital
Alongside Mutual Capital, whose fund investors are executives from US companies, in the B round were VC peers Excel Medical Ventures and HealthCare Ventures and the Cleveland Clinic.
Yahoo gains Stamped’s approval
Yahoo buys Stamped, a US-based social recommendations company backed by a consortium including Google Ventures.
Stanford’s global impact revealed
The 2011 Alumni Innovation Survey found there were 39,900 active companies, such as Google and Hewlett-Packard, that could be traced back to Stanford, which would make it the 10th largest economy in the world.
Pfizer takes up NextWave option
In the second quarter, Pfizer had paid $20m for an option to buy NextWave. Pfizer will pay a further $245m if the acquisition is approved and up to $425m in performance fees after Quillivant XR goes on sale in January.